Rivera R
Family Health International, Research Triangle Park, North Carolina 27709.
Ann Med. 1993 Feb;25(1):57-60. doi: 10.3109/07853899309147858.
Research in developing countries is essential for the evaluation of the safety, efficacy and acceptability of both new and already available contraceptives. Research conducted by scientists in developing countries has also played an essential role in the development of new contraceptives. The continuous delivery of progestin at a low dose, copper IUDs, contraceptive implants, monthly injectables and vaginal rings are examples of new methods developed with the input of research conducted largely in developing countries. When research in developing countries is funded or coordinated by international agencies, local scientists have to be involved not only in its implementation, but in the planning, analysis and dissemination of such research. The World Health Organization, the Population Council and Family Health International have played an important role in supporting collaborative studies for the development, introduction and evaluation of family planning methods in developing countries.
在发展中国家开展研究对于评估新型及现有避孕药具的安全性、有效性和可接受性至关重要。发展中国家的科学家所进行的研究在新型避孕药具的研发中也发挥了关键作用。低剂量孕激素的持续释放、铜宫内节育器、避孕植入物、每月注射剂和阴道环等都是主要在发展中国家开展的研究投入下研发出的新方法实例。当发展中国家的研究由国际机构资助或协调时，当地科学家不仅要参与研究的实施，还要参与研究的规划、分析和传播。世界卫生组织、人口理事会和国际家庭健康组织在支持发展中国家计划生育方法的开发、引进和评估的合作研究方面发挥了重要作用。
